As of 2025-06-22, the Relative Valuation of Panaxia Labs Israel Ltd (PNAX.TA) is (194,755.47) ILS. This relative valuation is based on P/E multiples. With the latest stock price at 4,738.00 ILS, the upside of Panaxia Labs Israel Ltd based on Relative Valuation is -4210.5%.
The range of the Relative Valuation is (186,493.11) - (270,690.43) ILS.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 15.0x | 9.7x |
| Forward P/E multiples | 9.5x - 13.8x | 10.1x |
| Fair Price | (186,493.11) - (270,690.43) | (194,755.47) |
| Upside | -4036.1% - -5813.2% | -4210.5% |
| Date | P/E |